A combination of adenosine (Ado) and homocysteine (Homo) enhances tumor necrosis factor (TNF)-α cytotoxicity in vitro and in vivo in several tumor cells. Ado and Homo at concentrations that enhanced TNF-α-mediated cytotoxicity accumulated S-adenosylhomocysteine (AdoHcy) and as consequence decreased the cellular methylation state, i.e. the ratio of S-adenosylmethionine to AdoHcy. This decrease led to inhibition of the isoprenylcysteine carboxyl methyltransferase (MTase), an enzyme that catalyzes carboxyl methylation of C-terminal cysteine residues on isoprenylated proteins. The effect of Ado and Homo on TNF-α cytotoxicity was at least partly mimicked by S-farnesylthioacetic acid, a selective inhibitor of the isoprenylcysteine carboxyl MTase, suggesting involvement of methylations of prenylated proteins in TNF-α-mediated cytotoxicity. Blockage of methylation reactions was associated with an enhancement of the TNF-αinduced disruption of the mitochondrial membrane potential (∆Ψ m ). In nude mice, a combination of Ado, Homo and TNF-α led to TNF-α-induced hemorrhagic necrosis and growth inhibition of TNFsensitive L929 tumors, whereas little effect was observed with TNF-α alone. Even more important, the TNF-resistant L929 M1 tumors were rendered TNF-sensitive by the combined action of Ado and Homo. We conclude that Ado and Homo together enhance the effectiveness of TNF-α in vitro and in vivo, results that may have therapeutic implications.
Introduction
Tumor necrosis factor (TNF)-α is a cytokine that is capable of inducing hemorrhagic necrosis in vivo (1) . In vitro, TNF-α exerts cytostatic and cytotoxic activity against a number of human and murine tumor cells, but spares most non-transformed cell lines (2) . TNF-α-induced cytotoxicity emanates from TNF-α receptor 1 (55-60 kDa) (3) (4) (5) . Upon oligomerization of TNF-α receptor 1 by trimeric TNF-α, TRADD is recruited to the receptor complex. TRADD then binds FADD/MORT1 (6) , which in turn recruits caspase-8 (FLICE, MACH, Mch5) (7) to the receptor complex. Caspase-8 is considered to play a role in the activation of other proteases that are responsible for the execution of cell death. Recently, it has been proposed that TNF-α-mediated cell death in L929 cells proceeds in a caspase-independent manner (8) . TNFα-induced cytotoxicity includes also the G-protein coupled Correspondence to: V. Lehmann Transmitting editor: T. Hünig Received 10 September 1998; accepted 10 December 1998 activation of phospholipase A 2 (9) , the generation of reactive oxygen intermediates (10, 11) and DNA damage (12) . Many tumor cells resist the cytotoxic action of TNF-α. However, TNF-α sensitivity can be induced in most of these cells by chemically blocking de novo protein synthesis (13) . This effect is due to inhibition of the synthesis of proteins that protect cells against the cytotoxic action of TNF-α. These proteins include the TNF-α-inducible manganese superoxide dismutase (MnSOD) that destroys superoxide radicals (14, 15) or the inhibitor of apoptosis proteins c-IAP1 and c-IAP2 that inhibit specific caspases (16, 17) . It has also been demonstrated that TNF-α induces the opening of mitochondrial permeability transition (PT) pores, resulting in a reduction of the mitochondrial transmembrane potential (∆Ψm) (18) . Moreover, it was shown that the mito-chondrial PT constitutes a critical early event of the death process (19, 20) . PT pores function as sensors for multiple physiological effectors including ATP, ADP, NAD, pH, thiols and peptides, and are thereby capable of integrating information on the metabolic and redox state of the cell. The exact composition of the PT pore is not known. However, it appears that at least one inner mitochondrial transmembrane protein, the adenine nucleotide translocator (ANT), is involved in PT formation (21) . ANT associates with several molecules of the outer mitochondrial membrane, including the voltagedependent anion channel. ANT ligands such as bongkrekic acid (BA) reduce the probability of PT (22) .
It was previously suggested that TNF-α-induced cytotoxicity is influenced by S-adenosylmethionine (AdoMet)-dependent methylation reactions (23) . Such processes may include methylation of proteins with isoprenylated cysteine residues at their C-terminus (24) . Many of these proteins function in signal transduction cascades across the plasma membrane. There are two types of isoprenyl groups, C 15 farnesyl and the more abundant C 20 geranylgeranyl groups. Proteins in the 21 and 28 kDa class, which include members of the Ras superfamily of small guanine nucleotide-binding proteins (Gproteins), are mainly geranylgeranylated, while p21 ras itself, the γ-subunit of the heterotrimeric large G-proteins, the cGMP phosphodiesterase and the nuclear lamins are farnesylated. Isoprenylated proteins initially contain a C-terminal sequence, CAAX, where A is an aliphatic amino acid and X any amino acid. A C 15 farnesyl or a C 20 geranylgeranyl group is then added to the cysteine residue to form a thioether. The terminal AAX is next removed to produce a C-terminal isoprenylated cysteine. Finally, the modified C-terminal cysteine is then carboxyl methylated in a AdoMet-dependent reaction. The methyl esterification is catalyzed by the isoprenylcysteine protein carboxyl methyltransferase (MTase), an enzyme that also methylates isoprenylated analogs of cysteine (24) . Unlike other classes of carboxyl MTase that are cytosolic, the isoprenylated protein MTase is membrane associated. The carboxyl methylation is reversible and may, therefore, play a regulatory role in signal transduction.
Transmethylation reactions utilize AdoMet as a methyl donor, converting it to S-adenosylhomocysteine (AdoHcy), which in turn is a potent inhibitor of AdoMet-dependent transmethylation reactions (25) . The immediate metabolic fate of AdoHcy involves its hydrolysis to adenosine (Ado) and Lhomocysteine (Homo) by the enzyme AdoHcy-hydrolase. An important property of this hydrolysis reaction is that it is readily reversible. Thus, for AdoHcy hydrolase to remove potentially inhibitory AdoHcy, it is necessary that either Ado or Homo or both be further metabolized in an efficient manner. In mammalian cells, the primary pathways for Homo metabolism are trans-sulfuration to cysteine or methionine. Ado is converted to either Ado phosphate by the Ado kinase or to inosine by Ado deaminase. Moreover, under conditions of Ado and Homo excess, reversibility of the hydrolytic reaction causes accumulation of AdoHcy and as consequence inhibition of methylation reactions.
We have used exogenous Ado and Homo as a tool to study the role of the cellular methylation state in TNF-α-mediated cytotoxicity. The present paper shows that a decrease of this state enhances TNF-α-mediated cytotoxicity in vitro. It provides evidence that the modulating effect is caused by a series of events that include a blockade of carboxyl methylations of prenylated proteins and an enhancement of the TNF-α-induced disruption of the mitochondrial membrane potential. Moreover, we show that the Ado and Homo-specific TNF-α potentiation can be extended to the in vivo antitumor action of TNF-α.
Methods

Cell lines
The TNF-resistant cell lines L929 M1, L929 M5 and HeLa R3 (3) were isolated in our laboratory. Both L929 cell lines are derivatives of the TNF-α-sensitive L929 cell line (unpublished work). L929 M1 cells express increased amounts of MnSOD. L929 M5 cells are resistant to TNF-α and to the combined action of Ado, Homo and TNF-α. The HeLa R3 cell line is a derivative of the TNF-α-sensitive HeLa S cell line (3) . All these strains were obtained by culturing highly TNF-α-sensitive parent strains in the presence of TNF-α (L929 M1 and HeLa R3) or in the presence of Ado, Homo and TNF-α (L929 M5). TNF-α-resistant or Ado/Homo and TNF-α-resistant clones were then isolated by limiting dilution. The properties of these clones will be described elsewhere. The TNF-sensitive cell lines, including murine L929 and WEHI fibrosarcoma cells, HeLa S cervix carcinoma cells as well as the TNF-resistant cell lines, including human PLC hepatoma cells, human A549 carcinoma cells and human ovarial adenocarcinoma SK-OV-3 cells, were obtained from the DKFZ collection.
All cell lines were incubated in culture medium: RPMI 1640 supplemented with 10% heat-inactivated (30 min at 56°C) newborn calf serum, penicillin (100 U/ml), streptomycin (100 µg/ml), HEPES (5 mM) and mercaptoethanol (3ϫ10 -5 M).
Recombinant human TNF-α with an activity of 5ϫ10 7 U/mg was obtained by courtesy of Bender (Vienna, Austria).
BA was kindly provided by Dr Duine (Delft University of Technology, Delft, the Netherlands).
Cytotoxicity assay
The cytotoxic activity of TNF-α was determined by a colorimetric assay (MTT test) (26) . L929 cells were seeded at a density of 10 4 cells/well in 96-well microtiter plates (flat bottomed) and incubated for 18-24 h in 0.2 ml culture medium. The supernatant was then removed and replaced by fresh medium containing serial dilutions of TNF-α and actinomycin D (1 µg/ ml). Incubation was continued for 18 h followed by addition of 10 µl of a MTT solution (5 mg/ml PBS). After another 4 h incubation, supernatants were removed followed by addition of 100 µl of a isopropanol:HCl solution (isopropanol and 1 N HCl, 24:1, v/v). The absorbance of each well was determined with an automated plate reader (SLT Easy Reader EAR 400 AT) at 550 nm. Survival was calculated as the percentage of the staining value of untreated cultures. Percent cytotoxicity is the difference between control (100%) and percent survival.
Determination of cellular AdoMet and AdoHcy
L929 cells were seeded in six-well plates (2.5ϫ10 6 cells/well) and permitted to grow at 37°C. Cells were then incubated 1 h with test substances and removed by scraping. They were Regulation of TNF-α cytotoxicity by the cellular methylation state 521 To examine cytotoxicity L929 cells were seeded in 96-well plates at a density of 10 4 cells/well. After 24 h test substances (1 mM each) were added followed by TNF-α and actinomycin D (1 µg/ml) and TNF-α. Incubation was continued for additional 18 h and cytotoxicity was determined by the MTT test. The results are the mean Ϯ SEM of four determinations.
To measure AdoHcy and AdoMet, L929 cells were seeded in six-well microtiter plates (2.5ϫ10 6 cells/well) and permitted to grow at 37°C. Cells were then incubated for 2 h with test substances and then removed by scraping. They were suspended in PBS followed by centrifugation. Cell pellets were extracted with cold 2.5% sulfosalicylic acid. Analysis was performed by HPLC. The values were obtained from one representative out of three experiments. resuspended in 2 ml PBS and cell suspensions centrifuged at 7000 g for 20 s in an Eppendorf microfuge. Cell pellets were extracted with 200 µl ice-cold 2.5% sulfosalicylic acid and cell extracts centrifuged for 5 min at 10,000 g. The supernatants were stored at -70°C and measured (20 µl) within 48 h. Analysis was performed by HPLC (27) , utilizing a DuPont liquid chromatography Model 850, a Partisil 10 SCX column as well as a DuPont UV spectrophotometer with a wavelength detector to measure absorbancy at 234 nm. AdoHcy was eluted isocretically at ambient temperature at a flow rate of 0.5 ml/min. The mobile phase was 100 mM and 500 ammonium phosphate, pH 2.6, each, for determination of AdoHcy and AdoMet respectively.
Determination of the isoprenylcysteine carboxyl MTase activity
The test was based on the ability of C-terminal carboxyl MTase to use N-acetyl-S-farnesyl-L-cysteine (AFC) as substrate (28) . Cells were incubated in Petri dishes (10 6 cells/dish) and incubated for 24 h. Cells were then scraped off the plates, washed with PBS and lysed by sonification in buffer A (100 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, 1 mM DTT, pH 7.9). Cell extracts were incubated with AFC (100 µM) and [ 3 H-methyl]AdoMet (1 µCi, sp. act. 60-80 Ci/mmol; DuPont NEN, Dreieich, Germany) in buffer A in a total volume of 100 µl for 25 min. The level of [ 3 H-methyl]AFC methylester was determined by extraction with hexan (0.5 ml). Radioactivity in the hexan phase was then measured by scintillation counting.
Assessment of mitochondrial potential
To evaluate mitochondrial potential (∆ψ m ), L929 (10 6 cells/ well) were incubated overnight in six-well plates. Cells were then washed with culture medium followed by addition of Ado and Homo (1 mM, each) and/or TNF-α at the indicated concentration. After the indicated periods of time the loss of the ∆ψ m was evaluated by flow cytometry using the fluorochrome 3,3Ј-dihexyloxacarbocyanine iodide (DiOC 6 (3)) (100 nM in PBS) (19) . The percentage of cells with low ∆ψ m is shown.
Experimental Animals
Female nude mice, 6-8 weeks old, were used (Swiss nu/nu; Iffa Credo, St Germain-sur-l'Arbresle, France).
Results
Influence of the cellular methylation state on TNF-α-mediated cytotoxicity
The cellular methylation state is defined by the ratio of AdoMet to AdoHcy and determines the ability of cells to methylate target structures (25) . This ratio is 16 in L929 cells growing in culture medium (see Table 1 ). When TNF-α was added to L929 cells, the ratio of AdoMet to AdoHcy declined within 2 h in a dose-dependent manner. Decrease was detectable at a concentration of 1000 pg/ml and maximum decrease (from 16 to 10.4) was observed at 10,000 pg/ml TNF-α. During this time period the internal pool of AdoHcy did not change but the amount of AdoMet decreased. This suggested that TNFα decreased the AdoMet:AdoHcy ratio by inhibiting AdoMet synthesis or by stimulating the consumption of AdoMet.
We next modulated the TNF-α-induced decrease of AdoMet: AdoHcy and determined the effect of this modulation on TNFα-mediated cytotoxicity. In order to achieve modulation, we used a combination of Ado and Homo that causes the reversible enzyme AdoHcy hydrolase to synthesize AdoHcy (23, 28) and as a consequence to decrease the AdoMet: AdoHcy ratio. As shown in Table 1 dependent manner but were unable to induce cell death. Ado and Homo at a concentration of 1 mM lowered the ratio from 16 to 0.35. A similar decrease of this ratio was obtained, when Ado and Homo (1 mM, each) were combined with low amounts of TNF-α (10 pg/ml) that, by itself, induced Ͻ10% cytotoxicity and were unable to alter the AdoMet:AdoHcy ratio. Most importantly, this decrease of the AdoMet:AdoHcy ratio was associated with a marked enhancement of the TNFα-induced cytotoxicity (from 7 to 99%). The results confirm and extend previous findings, showing that Ado and Homo together are unable to trigger cell death by themselves, but are capable of enhancing TNF-α-mediated cytotoxicity in L929 cells (23) . 
Changes in intracellular AdoHcy/AdoMet content and isoprenylcysteine carboxyl MTase activity in response to Ado and Homo
Decrease of the AdoMet:AdoHcy ratio leads to inhibition of AdoMet-dependent methylation reactions of various cellular target structures including proteins. Therefore, we asked what critical methylation reactions are involved in the potentiation of TNF-α-mediated cytotoxicity? To answer this question, we focused on methylation of prenylated proteins, which are thought to participate in signal transduction processes. Enzymes that mediate methylations of such proteins include the isoprenylcysteine carboxyl MTase. To examine the relationship between AdoMet:AdoHcy ratio and the activity of the isoprenylcysteine carboxyl MTase, two parallel groups of L929 cultures were set up and exposed to Ado and Homo (1 mM each). After various times the amounts of AdoMet and AdoHcy were determined in one group and carboxyl MTase activity in the other group. As expected, untreated L929 cells contained 400 pmol/10 6 cells AdoMet and~26 pmol/10 6 cells AdoHcy (see Fig. 1A ) resulting in a AdoMet:AdoHcy ratio of 15.3. When Ado and Homo (1 mM each) were added, the amount of AdoMet remained rather constant between 400 and 420 pmol/10 6 cells. In contrast, AdoHcy levels increased and after 1 h reached a maximum value of 990 pmol/10 6 cells, resulting in a cellular methylation ratio of 0.40. Moreover, accumulation of AdoHcy, induced by the combination of Ado and Homo, was closely associated with a decrease of the Cterminal isoprenylcysteine protein carboxyl MTase activity. Loss of enzyme activity was complete when AdoHcy rose to maximum levels. In contrast, Ado or Homo alone generated Ͻ200 pmol/10 6 cells within 1 h and were unable to decrease this enzyme activity (not shown). Similarly, TNF-α (10 pg/ml) did not decrease enzyme activity or modulate Ado and Homoinduced changes of enzyme activity (data not shown).
Loss of carboxyl MTase activity was also achieved when cell extracts were directly exposed to AdoHcy. Decrease of enzyme activity was observed with 0.01 mM AdoHcy while complete loss of activity was observed with 1 mM (see Fig. 1B ). 
Farnesylcysteine analogs enhance TNF-α-mediated cytotoxicity
To further investigate the role of carboxyl methylation of isoprenylated proteins, we studied the effect of two farnesyl-cysteine analogs that were previously shown to enter cells and to inhibit carboxyl methylation of Ras and Ras-related proteins (24, 28) . These analogs included AFC, a substrate and competitive inhibitor of the C-terminal isoprenylcysteine carboxyl MTase as well as S-farnesylthioacetic acid (FTA), a poor substrate but good inhibitor of this enzyme (24) . As shown in Fig. 2 , both compounds modulated TNF-α-induced cytotoxicity. AFC at 20 µM, a concentration that equals the Michaelis constant of AFC for carboxyl MTase (28), enhanced TNF-α-mediated cytotoxicity. Doses of AFC up to 100 µM caused no cell death, but were less efficient than 20 µM AFC (data not shown). Similarly, FTA at a concentration of 10 µM enhanced TNF-α-mediated cytotoxicity.
Ado and Homo modulate the ability of TNF-α to destroy the mitochondrial membrane potential Disruption of the mitochondrial membrane potential (∆ψ m ) is thought to be a crucial event in the cellular commitment to the cell death program, including TNF-α-induced cytotoxicity (19, 20) . Therefore, we investigated the depolarization of the mitochondrial membrane in response to TNF-α in the presence or absence of Ado and Homo and actinomycin D. Accordingly, L929 cell cultures received test substances, and after 3 and 7 h of incubation changes of the mitochondrial membrane potential were evaluated by using the fluorochrome DiOC 6 (3) (19) . As shown in Fig. 3(A-C) , TNF-α alone at 10 and 100 pg/ml did not alter the percentage of cells with low ∆ψ m 3 and 7 h after TNF-α addition. Similarly a modest disruption of ∆ψ m was noted when cells were treated with TNF-α (100 pg/ml) in the presence of actinomycin D (1 µg/ml). After 7 h almost 18% of the cells expressed low ∆Ψ m (Fig. 3C) . No change was observed with 10 pg/ml TNF-α and actinomycin D at the same time point. However, addition of TNF-α in combination with Ado and Homo destroyed ∆Ψ m in an efficient manner: At 3 h after addition of TNF-α (10 and 100 pg/ml) the percentages of cells with low ∆Ψ m were 29% (Fig. 3A and B) and 50% (Fig. 3A) respectively, and increased to 70 and 82% after 7 h (Fig. 3C) . In contrast, the combination of Ado and Homo (1 mM, each), or actinomycin D without TNF-α did not decrease ∆Ψ m.
BA inhibits TNF-α-mediated cytotoxicity in the presence and absence of Ado and Homo
It was previously suggested that the collapse of the ∆Ψ m may be due to the opening of mitochondrial PT pores (19) . In accord with this hypothesis it was observed that a specific ligand of the mitochondrial adenine nucleotide translocator Fig. 3 . TNF-α-induced disruption of mitochondrial membrane potential in the presence and absence of Ado and Homo. L929 cells (10 6 / well) were placed in six-well plates and incubated overnight. Cells were then washed with culture medium, and then received Ado, Homo (1 mM, each) and/or TNF-α (10 or 100 pg/ml) and actinomycin D (1 µg/ml). Incubation was then continued. After 3 (A and B) and 7 (C) h mitochondrial potential of mitochondria (∆Ψm) was assessed by flow cytometry, using the fluorochrome (DiOC 6 (3)) (20) . The results are representative of three experiments. Control mitochondria treated with the ∆ψ m -disrupting protonophore m-chlorophenylhydrazone (CCCP) (100 µM) served as negative control (unfilled curve in control). (ANT), bongkrekic acid (BA), inhibits PT and prevents death of cells exposed to various inducers (19) . Therefore, we examined the ability of BA to modulate the TNF-α cytotoxicity in the presence and absence of Ado and Homo. As shown in Fig. 4 , BA at least partially reduced the TNF-α-induced cytotoxicity in the presence and absence of Ado and Homo. These results support the hypothesis that the opening of PT is indeed involved in both TNF-α-, and Ado, Homo and TNFα-mediated cytotoxicity.
Ado and Homo exert their enhancing potential on various tumor cells
In subsequent studies we examined whether the potentiating effect of Ado and Homo on TNF-α-mediated cytotoxicity occurs also in other tumor cells. Several murine and human tumor cell lines were employed to study the effect of Ado and Homo on the cytotoxic activity of TNF-α. Three strains were TNF sensitive (L929, WEHI and HeLa S) while five cells lines (HeLa R3, mutant L929 M1, A549, PLC and SK-OV-3) were TNF resistant. As seen in Fig. 5 , combinations of Ado and Homo enhanced TNF-α cytotoxicity in TNF-sensitive strains and converted TNF-resistant into TNF-sensitive tumor cells. In all cases, the effect of Ado and Homo was dose dependent. At the concentration used (1 and 0.5 mM), Ado and Homo did not affect cell viability in the absence of TNF-α.
Ado and Homo together enhance the in vivo antitumor action of TNF Subcutaneous injection of 10 6 TNF-α-sensitive L929 cells into nude mice yielded fast-growing tumors. The tumors were allowed to grow for 4 days. Mice received then Ado and Homo, TNF-α, or TNF-α and Ado and Homo perilesionally for several periods of five consecutive days, interrupted by 2 days without treatment. The doses of TNF-α (10 µg) and Ado and Homo (1 mg, each) were kept constant. The results of a representative experiment are shown in Fig. 6(A) . Compared with TNF-α alone, the combination of TNF-α, Ado and Homo was very effective. Ado and Homo alone had no effect. From the second week on, most of the tumor exhibited signs of necrosis following treatment with either TNF-α or TNF-α and Ado and Homo. However, while growth inhibition induced by TNF-α was generally modest, no tumor growth was observed with TNF-α in the presence of Ado and Homo. In some cases tumor sizes increase and after the second week on decrease (Fig. 6A ). After prolonged treatment (100 days) with TNF-α, Ado and Homo, 80% of these mice were completely free of tumors.
We next injected TNF-resistant L929 M1 cells s.c. into nude mice (10 6 cells/mouse) and treated mice as described above. The result of a representative experiment is shown in Fig.  6(B) . In this experiment, TNF-α or Ado and Homo had no detectable effect on tumor growth. In contrast, a combined treatment with TNF-α, Ado and Homo led to growth inhibition. After 22 days all these mice were tumor-free. Again, after prolonged (100 days) treatment with TNF-α, Ado and Homo, 60% of the mice carried no tumor.
To examine whether the in vivo effect of Ado and Homo was direct or indirect, L929 M5 cells (10 6 per mouse) were employed that resist the combined action of Ado, Homo and TNF-α (Fig. 6C ). The tumors were treated according to the protocol mentioned above. After 3 weeks neither treatment proved effective to inhibit tumor growth ( Fig. 6D) . These results suggest that most of the responses observed in vivo with the TNF/Ado/Homo-susceptible L929 and L929 M1 cells were due to direct actions of TNF-α, Ado and Homo. 
Discussion
This report shows that a combination of Ado and Homo modulates in vitro and in vivo the sensitivity of several tumor cells towards the cytotoxic action of TNF: it potentiates TNF-α-mediated cytotoxicity in TNF-sensitive tumor cells and converts TNF-resistant tumor cells into TNF-sensitive cells. Moreover, the paper provides information about the mechanism underlying the potentiating effect of Ado and Homo.
Ado and Homo were used as a tool to alter the methylation state. When these compounds are added they enter cells and force the reversible enzyme AdoHcy hydrolase to synthesize AdoHcy and to decrease the AdoMet:AdoHcy ratio (25) .
Decrease of the AdoMet:AdoHcy ratio was associated with the inhibition of the isoprenylcysteine carboxyl MTase, an enzyme that catalyzes methylation of carboxyl groups of the C-terminal residues on isoprenylated proteins. To further investigate the role of carboxyl methylations in the modulation of TNF-α-meddiated cytotoxicity, we studied the effect of farnesylcysteine analogs such as AFC and FTA. Both compounds were shown previously to enter cells and to inhibit carboxyl methylations of isoprenylated proteins (24) . We observed that these compounds are able to mimick, at least partially, the potentiating effect of Ado and Homo, suggesting that carboxyl methylations are indeed involved in the modulation of the TNF-α-induced cytotoxicity.
Next we investigated the ability of Ado and Homo to influence the TNF-α-induced collapse of the mitochondrial membrane potential (∆Ψ m ). Disruption of ∆Ψ m is thought to be a central executioner for cell death and marks a point of no return for the induction of cell death (19, 20) . Here we confirm an earlier observation that TNF-α is capable of reducing the mitochondrial membrane potential (18) , but more important we show that this process is modulated by the methylation status. We observed that the combination of Ado and Homo potentiated the TNF-α-induced disruption of the mitochondrial potential in L929 cells.
Both TNF-α-and Ado/Homo/TNF-α-induced cytotoxicity are, at least partially, inhibited by BA, a specific ligand of the mitochondrial ANT. ANT is considered as a component of the permeability transition pore and cooperates with other proteins including the voltage-dependent channel proteins (22) . Therefore, our findings suggest that the TNF-α-and the Ado/Homo/ at Pennsylvania State University on February 23, 2013 http://intimm.oxfordjournals.org/ Downloaded from TNF-α-induced disruption of the mitochondrial potential are partially due to the opening of mitochondrial permeability pores.
We have also addressed the question whether the cytotoxic effect in vitro and the antitumor effect in vivo are the result of the same bioactivity of TNF-α. We have shown that tumor cells, i.e. L929 M5 cells that are resistant to the combined action of Ado, Homo and TNF-α, fail to respond in vivo. This suggests that the in vivo action of TNF-α, Ado and Homo is mainly direct.
At the moment it is unclear how Ado and Homo-induced alterations of the cellular methylation status influence the TNFα-mediated cytotoxicity. However, we propose the following working hypothesis. In the absence of Ado and Homo, the methylation status permits AdoMet-dependent methylation reactions, including carboxyl methylation of prenylated proteins that suppress TNF-α-inducible cytotoxic pathways. In the presence of Ado and Homo the cellular methylation state (ratio of AdoMet:AdoHcy) is decreased and as a consequence carboxyl methylations are blocked. This opens a TNF-αinducible cytotoxic pathway that leads to the collapse of the mitochondrial membrane potential. Currently there is no evidence that Ado, Homo or AdoHcy act at the cell surface and induce some kind of signal that influences the methylation state. For instance agents that prevent binding of Ado to the Ado receptors do not block potentiation of TNF-α cytotoxicity. Moreover, it is known that AdoHcy is unable to enter the cell (24) . When this compound was added to L929 cells no enhancement of TNF-α cytotoxicity was observed (unpublished results).
Proteins that have such C-terminal modifications include members of the Ras superfamily such as the γ subunit of the heterotrimeric G-binding proteins. Many of these proteins are involved in signal transduction processes. For instance, certain heteromeric G-binding proteins are quite effective in their methylated form in activating enzymes such as phosphoinositol-3-kinase and phospholipase C-β, whereas their unmethylated counterparts are virtually inert (29, 30) . Moreover, phosphoinositol-3-kinase and phospholipase C-β are implicated in a pathway that conveys survival signals from various cell surface receptors to mitochondria (31,32,) . Our current effort focuses on the identification of the prenylated protein that mediate the Ado and Homo-induced effect on TNF-α cytotoxicity.
In conclusion, our results provide evidence that a combination of Ado and Homo potentiates the TNF-α cytotoxicity by a mechanism which involves a decrease of the cellular methylation state, the down-regulation of the isoprenylcysteine protein MTase activity and, finally, a decrease of the threshold for the TNF-α-induced opening of mitochondrial PT pores. Moreover, the considerable potentiation of TNF-α cytotoxicity in vitro and in vivo by Ado and Homo might be helpful to develop new strategies to human cancer therapy.
